Work

Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells

Year: 2024

Type: editorial

Source: Oncogene

DOI: 10.1038/s41388-024-03147-5

Authors: Teru Hideshima, Klaus Podar, Dharminder Chauhan, Kenji Ishitsuka, Constantine Mitsiades, Yu-Tzu Tai, Makoto Hamasaki, Noopur Raje, Hiromasa Hideshima, George Schreiner, Aaron N. Nguyen, Tony Navas, Nikhil C. Munshi, Paul G. Richardson, Linda S. Higgins, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4401993605

Cites:

Cited by: 1

Related to: 10